Career disposition track record across Sunnyvale, Mountain View, Fremont, and Palo Alto R&D corridors. Lab, flex, and tech-occupant institutional sales advisory.
While office headlines dominated the post-2020 narrative, the Silicon Valley R&D corridor has quietly outperformed every other Bay Area asset class. Reason: tenant demand from biotech, semiconductor design, AI hardware, and tech-occupant manufacturing has structurally expanded while supply remains tightly constrained by zoning. Submarkets like Sunnyvale's Moffett Park, Mountain View's North Bayshore, and Fremont's Warm Springs continue to see pre-leasing on speculative product.
The institutional buyer pool for R&D is deeper and more focused than for general office: Alexandria Real Estate Equities, BioMed Realty (Blackstone), Healthpeak, IQHQ, and a long tail of specialist sponsors are active buyers. Family offices increasingly view R&D as the "office adjacent" asset class with secular tailwinds.
What makes R&D disposition different from office disposition: tenant build-out value, the difference between wet-lab-ready and dry-lab product, parking ratios, ceiling heights, dock-high access, and proximity to anchor research institutions all influence pricing more than location alone.
R&D disposition is technical work. The institutional buyer pool will not engage on partial information. Our process is built to deliver complete information from day one.
Technical asset profile. Detailed build-out inventory: clean room class, vibration tolerances, power capacity, redundancy, HVAC, fume hood counts, biosafety levels, dock access, ceiling heights. This information determines which buyer pool is the right target.
Specialized buyer targeting. Beyond the obvious REITs (Alexandria, BioMed, IQHQ), we maintain a network of specialized sponsors and tenant capital that transact selectively on R&D when the alignment is right. Many of these buyers don't bid through standard brokerage marketing — they need to be sourced directly.
Tenant intelligence layer. Where the asset has tenant rights of first offer, right of first refusal, or expansion options, the disposition strategy starts with the in-place tenant. Often the best buyer is already in the building.
The R&D buyer universe is small and relationship-driven. The first conversation maps your asset against the active capital pools and identifies the right execution path — direct strategic, broad institutional, or tenant-driven.